CAS vs Standard Technique in TKA: Comparison of Clinical and Functional Results
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Sep 19, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different surgical methods for total knee replacement surgery, which is a common procedure for people with severe knee pain, often due to arthritis. The study will look at how well each technique works, how much bleeding occurs during surgery, and the overall costs related to the surgery, such as how long patients stay in the hospital. The researchers aim to enroll 160 patients, who will be divided into two groups of 80, with one group using the standard surgical method and the other using a computer-assisted technique.
To be eligible for this study, participants must be at least 45 years old and have a medical recommendation for knee replacement surgery. They should also be willing to participate and able to give their consent. However, those who cannot understand the information about the study, refuse to participate, have a nickel allergy, or are pregnant (or could become pregnant) cannot join. If you take part in this trial, you can expect close monitoring during your surgery and recovery to help determine which technique works best.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with primary or secondary gonarthrosis with indication for knee arthroplasty with primary implant
- • Males and females aged ≥ 45
- • Willingness to participate in the study
- • Acquisition of informed consent to participate
- Exclusion Criteria:
- • Patients who are not capable of understanding and willing, and therefore unable to express consent to participation in the study
- • Patient refusal to participate in the study and to sign the informed consent
- • Nickel allergy (suspected or diagnosed)
- • Pregnant women or women of childbearing age who cannot exclude pregnancy
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported